Amicus Therapeutics (FOLD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -27,110 | -56,106 | -151,584 | -236,568 | -250,460 |
| Depreciation Amortization | 10,030 | 10,809 | 10,489 | 7,976 | 8,699 |
| Income taxes - deferred | 0 | 0 | -4,939 | 9 | 34 |
| Accounts receivable | -5,860 | -19,484 | -20,108 | -17,330 | -8,189 |
| Other Working Capital | -39,633 | -98,943 | -47,990 | -39,880 | -28,938 |
| Other Operating Activity | 95,718 | 129,833 | 145,041 | 119,218 | 76,363 |
| Operating Cash Flow | $33,145 | $-33,891 | $-69,091 | $-166,575 | $-202,491 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -43,136 | 2,993 | 105,504 | 92,671 | 82,645 |
| PPE Investments | -3,296 | -3,553 | -7,440 | -355 | -3,884 |
| Investing Cash Flow | $-46,432 | $-560 | $98,064 | $92,316 | $78,761 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 387,360 | N/A | 0 |
| Debt Repayment | -272 | -97 | -408,318 | -283 | -479 |
| Common Stock Issued | 19,205 | 27,243 | 103,208 | 4,310 | 229,208 |
| Common Stock Repurchased | -18,323 | -22,025 | -17,920 | -11,490 | -15,009 |
| Other Financing Activity | 0 | 0 | -2,653 | 0 | -1,647 |
| Financing Cash Flow | $610 | $5,121 | $61,677 | $-7,463 | $212,073 |
| Exchange Rate Effect | 13,277 | -4,031 | 6,312 | -14,619 | -5,049 |
| Beginning Cash Position | 216,716 | 250,077 | 153,115 | 249,456 | 166,162 |
| End Cash Position | 217,316 | 216,716 | 250,077 | 153,115 | 249,456 |
| Net Cash Flow | $600 | $-33,361 | $96,962 | $-96,341 | $83,294 |
| Free Cash Flow | |||||
| Operating Cash Flow | 33,145 | -33,891 | -69,091 | -166,575 | -202,491 |
| Capital Expenditure | -3,296 | -3,553 | -7,440 | -3,766 | -3,884 |
| Free Cash Flow | 29,849 | -37,444 | -76,531 | -170,341 | -206,375 |